Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value

Table 1

The GO and KEGG terms enriched by upregulated DEGs.

Category	Term	Count	P-Value
GOTERM_BP_FAT	GO:0030198~extracellular matrix organization	14	3.88E-12
GOTERM_BP_FAT	GO:0043062~extracellular structure organization	16	7.24E-12
GOTERM_BP_FAT	GO:0007049~cell cycle	28	2.27E-10
GOTERM_BP_FAT	GO:0000279~M phase	19	3.12E-10
GOTERM_BP_FAT	GO:0007067~mitosis	16	5.21E-10
GOTERM_CC_FAT	GO:0031012~extracellular matrix	21	6.61E-13
GOTERM_CC_FAT	GO:0005578~proteinaceous extracellular matrix	19	1.80E-11
GOTERM_CC_FAT	GO:0005576~extracellular region	42	1.61E-10
GOTERM_CC_FAT	GO:0044421~extracellular region part	28	8.32E-10
GOTERM_CC_FAT	GO:0044420~extracellular matrix part	12	9.61E-10
GOTERM_MF_FAT	GO:0005201~extracellular matrix structural constituent	9	2.58E-07
GOTERM_MF_FAT	GO:0048407~platelet-derived growth factor binding	4	6.59E-05
GOTERM_MF_FAT	GO:0004857~enzyme inhibitor activity	9	9.87E-04
GOTERM_MF_FAT	GO:0050840~extracellular matrix binding	4	0.001069556
GOTERM_MF_FAT	GO:0001871~pattern binding	7	0.001084076
KEGG_PATHWAY	hsa04512: ECM-receptor interaction	10	2.22E-09
KEGG_PATHWAY	hsa04510: Focal adhesion	10	4.37E-06
KEGG_PATHWAY	hsa04610: Complement and coagulation cascades	6	8.15E-05
KEGG_PATHWAY	hsa04110: Cell cycle	5	0.009122958
KEGG_PATHWAY	hsa04115: p53 signaling pathway	4	0.010179414

BP: biological process; CC: cellular component; MF: molecular function.